Home / Articles posted by Peter Göttel (Page 2)

Author: Peter Göttel

NEWS: Phase-1 clinical study 

Berlin Cures Holding AG announces start of phase-1 study of BC007 ZURICH (Switzerland), November 14, 2016 --  Berlin Cures Holding AG announces the start of the clinical Phase-1-first-in-human-study of its drug candidate BC007. The study is a 2-part design with part 1 being a randomized, double-blinded, ascending single-dose study in healthy subjects, followed by part 2, which is an open, ascen...
Read More